Mayur is finishing his Ph.D in Biomedical Engineering at Columbia University where he cofounded Ardent Cell Technologies, a cell therapeutics company entering clinical trials. Before joining Columbia he worked at Boston Consulting Group designing predictive models and precision medicine product pipelines for healthcare giants like Boston Scientific. He believes that opportunities shaping and contributing towards value based care are the way forward.
For any product or any company, anything you?re trying to build, the first thing you quantify is if there is a value proposition. Not just quantify it, analyze it, break it down, digest it and then build up your whole company around that value proposition because that is what decides what you want ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
